{"id":296664,"date":"2026-10-09T10:06:32","date_gmt":"2026-10-09T04:36:32","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=296664"},"modified":"2026-10-09T10:06:32","modified_gmt":"2026-10-09T04:36:32","slug":"why-mankind-pharma-share-consecutive-price-fall-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-share-consecutive-price-fall-2026\/","title":{"rendered":"Mankind Pharma (MANKIND) Share Price Fall Streak: stock declines for second straight session"},"content":{"rendered":"
Mankind Pharma (MANKIND)<\/a> share price fell to Rs 2,346.5 today, down 2.16% from the previous close. Market cap was Rs 1,03,048.55 crore.<\/em><\/div>\n

Mankind Pharma Share Price Fall Streak is in focus as the stock traded lower in its second straight session, with the cumulative move across the streak at -5.95% from Rs 2,494.85. At 09 October 2026 at 9:53:20 AM IST, the latest traded price was Rs 2,346.50. The price move is confirmed in Univest data; a company-specific reason has not been established.<\/p>\n

The company\u2019s market capitalisation stood at Rs 1,03,048.55 crore, which keeps it in the Large Cap category. For readers tracking Mankind Pharma Share Price Fall Streak, the key point is not only the one-session move but the fact that two lower sessions in a row change the way the stock is read versus a single-day decline. That streak context matters because the re-pricing is now measured across more than one session, while the underlying operating base has not changed within this short window.<\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n